Skip to content
Clinical Trial Events
ISPOR Europe 2026

Talk

Generating Decision-Ready Evidence for HTA and JCA

Tue, Nov 10, 2026 · 10:30–11:30 AM CET Theater 1, Hall X1-X4, Level -2, Austria Center Vienna

About this session

As HTA and Joint Clinical Assessment (JCA) requirements continue to evolve, decision-makers increasingly rely on evidence beyond direct head-to-head clinical trials. This session showcases the application of matching-adjusted indirect comparisons (MAICs), network meta-analysis (NMA), real-world evidence (RWE), and surrogate endpoint validation to address evidence gaps and support robust comparative effectiveness assessments.

Speaker